Calpis' AmealPeptide lowers blood pressure in 2 placebo-controlled trials

Two new clinical trials presented by Calpis Co., Ltd. at the American Society of Hypertension (ASH) Twenty-Third Annual Scientific Meeting and Exposition (ASH 2008) in New Orleans show that the milk-derived dietary supplement AmealPeptideĀ® reduces blood pressure in hypertensive patients.

Get the full story...

Reply

The content of this field is kept private and will not be shown publicly.
  • Lines and paragraphs break automatically.
  • Allowed HTML tags: <p> <br> <a> <em> <ul> <ol> <li> <strong> <blockquote>

More information about formatting options

4 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.